North America Male Artificial Urinary Sphincter Market, By Type (AUS with a Balloon Reservoir (3-Component), AUS with a Spring (2-Component)), By End User (Hospitals, Clinics & Other Health Centers, Academic & Research Centers), By Country, Competition, Forecast and Opportunities, 2019-2029F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationNorth America Male Artificial Urinary Sphincter Market, By Type (AUS with a Balloon Reservoir (3-Component), AUS with a Spring (2-Component)), By End User (Hospitals, Clinics & Other Health Centers, Academic & Research Centers), By Country, Competition, Forecast and Opportunities, 2019-2029F
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 109.06 Million |
| Market Size (2029) | USD 159.15 Million |
| CAGR (2024-2029) | 6.58% |
| Fastest Growing Segment | AUS with a balloon reservoir (3-component) |
| Largest Market | United States |
Market Overview
North America Male Artificial Urinary Sphincter Market was valued at
Male urinary incontinence, characterized by the involuntary leakage of urine, is a common condition, primarily affecting aging men. This demographic shift has resulted in a substantial increase in the prevalence of this condition, driving the demand for effective treatment options like male artificial urinary sphincters.
Key Market Drivers
Aging Population
The aging population is a significant driver of growth in the North America Male Artificial Urinary Sphincter Market. As individuals age, they are more prone to various health conditions, including urinary incontinence, which often necessitates medical intervention such as the implantation of artificial urinary sphincters. This demographic trend creates a growing market for these devices and associated procedures.
One key factor contributing to the increased prevalence of urinary incontinence among the aging population is the natural aging process itself. As people age, the muscles and nerves that control bladder function may weaken, leading to involuntary urine leakage. Age-related medical conditions such as prostate enlargement in men and pelvic floor disorders in both men and women can further exacerbate urinary incontinence.
Artificial urinary sphincters are among the treatment options found at for managing urinary incontinence, particularly in cases where conservative measures such as lifestyle modifications and medications have been ineffective. These devices mimic the function of the natural urinary sphincter by regulating the flow of urine from the bladder, thereby helping to control urinary leakage.
Advancements in medical technology have led to the development of more sophisticated and minimally invasive artificial urinary sphincters, which appeal to older adults seeking effective and less invasive treatment options. These technological innovations not only improve patient outcomes but also enhance the overall patient experience, leading to greater patient satisfaction and increased demand for these devices.
Also, demographic shifts such as the increasing proportion of older adults in the population pyramid contribute to market growth by creating a larger target market for artificial urinary sphincter manufacturers and healthcare providers. This demographic trend is expected to continue in the coming years, further fueling demand for these devices and procedures.
Advancements in Healthcare Technology
Advancements in healthcare technology play a pivotal role in driving the growth of the North America Male Artificial Urinary Sphincter Market. These advancements encompass a wide range of innovations, including improvements in the design and functionality of artificial urinary sphincters, advancements in surgical techniques, and the integration of digital health solutions. Together, these technological advancements enhance the efficacy, safety, and accessibility of artificial urinary sphincter procedures, thereby expanding the market and improving patient outcomes.
One key area of advancement in healthcare technology is the development of more sophisticated and minimally invasive artificial urinary sphincters. Traditional artificial urinary sphincters consisted of mechanical devices that required manual manipulation to regulate urinary flow. However, recent technological innovations have led to the introduction of programmable and adjustable devices that offer greater control and customization for patients. These next-generation artificial urinary sphincters utilize advanced materials and electronics to provide precise and reliable urinary continence control while minimizing the risk of complications.
In addition to improvements in device design and surgical techniques, the integration of digital health solutions has also played a significant role in driving market growth. Digital health technologies, such as telemedicine platforms, remote monitoring devices, and mobile health apps, enable healthcare providers to deliver more personalized and accessible care to patients undergoing artificial urinary sphincter procedures.
Mobile health apps provide patients with valuable resources and support tools to manage their condition effectively. These apps may include features such as symptom tracking, medication reminders, and educational content, empowering patients to take an active role in their healthcare journey and improve treatment adherence.
Also, advancements in healthcare technology have led to improvements in patient education and engagement, which are essential for driving adoption of artificial urinary sphincter procedures. Interactive educational materials, virtual reality simulations, and multimedia presentations help patients better understand their condition, treatment options, and expected outcomes, empowering them to make informed decisions about their care.
Rising Awareness and Education
Rising awareness and education play a critical role in driving the growth of the North America Male Artificial Urinary Sphincter Market. This heightened awareness encompasses various stakeholders, including patients, healthcare professionals, medical associations, advocacy groups, and healthcare organizations. Through educational initiatives, awareness campaigns, and information dissemination efforts, these stakeholders contribute to increasing understanding of urinary incontinence, found at treatment options, and the benefits of artificial urinary sphincters, thus fostering market expansion.
Healthcare professionals, particularly urologists and general practitioners, play a crucial role in raising awareness and educating patients about urinary incontinence and found at treatment modalities. Through continuing medical education programs, conferences, and professional associations, healthcare professionals stay updated on the latest developments in the field of urology and urinary incontinence management. This knowledge enables them to accurately diagnose patients, recommend appropriate treatment options, and advocate for the use of artificial urinary sphincters when indicated.
The advent of digital platforms and online resources has also contributed significantly to raising awareness about urinary incontinence and treatment options. Medical websites, social media platforms, online forums, and patient support groups provide valuable information, resources, and peer support to individuals affected by urinary incontinence. Patients can access educational materials, research articles, and testimonials from others who have undergone treatment with artificial urinary sphincters, empowering them to make informed decisions about their healthcare.
Reducing the stigma associated with urinary incontinence is another important aspect of rising awareness and education efforts. By raising awareness about the prevalence and impact of urinary incontinence, advocacy groups and healthcare organizations work to dispel myths and misconceptions surrounding the condition. This societal shift towards greater acceptance and understanding encourages individuals to seek help for urinary incontinence without fear of judgment or shame, thus increasing the demand for treatment options such as artificial urinary sphincters.
Reimbursement and Insurance Coverage
Reimbursement and insurance coverage are significant drivers of growth in the North America Male Artificial Urinary Sphincter Market. These factors directly impact the accessibility, affordability, and utilization of artificial urinary sphincter procedures, making them more attractive options for both patients and healthcare providers. By mitigating financial barriers and incentivizing healthcare facilities to offer these procedures, reimbursement and insurance coverage contribute to market expansion and the adoption of artificial urinary sphincters as a standard of care for managing urinary incontinence.
Insurance coverage for artificial urinary sphincter procedures encourages more patients to explore treatment options and undergo surgical intervention for urinary incontinence. When patients know that their insurance will cover the cost of the procedure, they are more likely to consider artificial urinary sphincters as a viable treatment option and pursue timely intervention for their condition. This increased demand for artificial urinary sphincter procedures translates into higher utilization rates and market growth.
Reimbursement from insurance providers often comes with specific coding and billing requirements that healthcare facilities must adhere to in order to receive payment. Compliance with these requirements ensures that healthcare facilities maintain regulatory compliance and adhere to recognized medical standards when performing artificial urinary sphincter procedures. This helps uphold the quality and safety of care delivered to patients, enhancing the reputation of healthcare providers and fostering trust among patients and referring physicians.
Also, the presence of reimbursement and insurance coverage for artificial urinary sphincter procedures is often linked to regulatory approval and endorsement by professional medical societies and organizations. Insurance providers typically require evidence of clinical efficacy, safety, and cost-effectiveness before providing coverage for new medical technologies and procedures. Therefore, healthcare manufacturers and providers invest in clinical research, evidence generation, and outcomes studies to demonstrate the value proposition of artificial urinary sphincters and secure reimbursement from insurance providers. This evidence-based approach strengthens the market position of artificial urinary sphincters and promotes their widespread adoption as a standard of care for managing urinary incontinence.
Key Market Challenges
High Procedure Costs
Male artificial urinary sphincter implantation is a surgical procedure that can be costly. The expense includes the cost of the device itself, surgical fees, anesthesia, and post-operative care.
For many patients, the high cost of the procedure can be a significant barrier to access. Even with insurance coverage, out-of-pocket expenses can be substantial. This financial constraint can deter individuals from seeking treatment, slowing down market growth. In some regions, insurance providers may not fully cover the cost of male artificial urinary sphincter procedures, leaving patients with a considerable financial burden. Reduced insurance coverage can impede the market's expansion by limiting patient access.
Stigma and Awareness
Male urinary incontinence is often associated with a certain level of social stigma. This stigma can prevent individuals from discussing their condition with healthcare professionals, leading to delayed diagnosis and treatment.
Despite efforts to raise awareness, many individuals, including healthcare providers, may still have limited knowledge about male urinary incontinence and the found at treatment options. Lack of awareness can hinder early intervention and impede market growth. Patients may fear disclosing their condition due to embarrassment or concerns about societal perception. This fear can lead to delayed treatment seeking, impacting the market's growth.
Complications and Revision Surgeries
While male artificial urinary sphincters are generally effective, complications can arise. These may include device erosion, infection, mechanical failure, or the need for device revisions. Complications can result in additional healthcare costs and reduce patient satisfaction.
The necessity of revision surgeries can pose challenges, as they are associated with additional costs, recovery time, and potential complications. Patients may be discouraged by the prospect of revision surgeries, and this can influence their decision to undergo the initial implantation procedure. Managing complications and revisions requires a high level of clinical expertise. Ensuring that healthcare providers have the necessary skills to handle such cases can be a challenge and may impact market growth.
Key Market Trends
Minimally Invasive Procedures
One of the most prominent trends in the male artificial urinary sphincter market is the increasing adoption of minimally invasive procedures for implanting these devices.
Minimally invasive techniques involve smaller incisions, reduced tissue damage, and shorter recovery times. This trend is driven by the desire to minimize patient discomfort and enhance the overall patient experience. As minimally invasive procedures become more widely adopted, they are likely to attract more patients who are hesitant about undergoing surgery. This trend contributes to the market's growth by expanding the pool of potential candidates for male artificial urinary sphincter implantation.
Personalized Treatment
Personalization and customization of male artificial urinary sphincter treatment plans are gaining prominence.
Segmental Insights
Type Insights
Based on Type, the AUS with a balloon reservoir (3-component) segment emerged as the dominant player in the North America market for Male Artificial Urinary Sphincter in 2023. AUS with a balloon reservoir, categorized as a 3-component system, is highly regarded for its effectiveness in managing male urinary incontinence. These devices are designed to mimic the natural sphincter's functioning, providing users with better control over their urinary flow. The three-component design, which typically includes a cuff, a pressure-regulating balloon, and a control pump, ensures precise control and minimizes leakage.
The balloon reservoir within the 3-component AUS offers a comfortable and discreet solution for patients. Its design ensures that the device remains compact and unobtrusive, contributing to greater patient comfort and ease of use. AUS with balloon reservoirs have garnered strong clinical endorsement and have been recognized as a reliable treatment option for male urinary incontinence. The effectiveness of this 3-component design is often backed by medical professionals, increasing patient trust and adoption.
The 3-component AUS allows for individualized adjustments. Physicians can tailor the device to the specific needs of each patient, ensuring optimal performance. This level of customization ensures a higher success rate and patient satisfaction. AUS devices with a balloon reservoir are known for their durability and longevity. This feature is particularly attractive to patients as it reduces the need for frequent replacements or adjustments. These factors are expected to drive the growth of this segment.
End User Insights
The hospitals segment is projected to experience rapid growth during the forecast period. Hospitals are hubs of clinical expertise, with urologists and other specialists who can accurately diagnose and recommend treatment for male urinary incontinence. The urological conditions that require artificial urinary sphincters often necessitate specialized care, which is readily found at in hospital settings. This makes hospitals the primary point of contact for patients seeking treatment for their condition.
The implantation of male artificial urinary sphincters is a surgical procedure that demands specialized skills and resources. Hospitals are equipped with state-of-the-art surgical facilities and trained surgical teams capable of performing these complex procedures with a high degree of precision and safety. The sterile environments, advanced technology, and support staff found at in hospitals ensure the successful implantation of artificial urinary sphincters. Post-surgical care is essential for patients who have undergone artificial urinary sphincter implantation. Hospitals provide comprehensive post-operative care, monitoring patients for any complications, and offering immediate interventions if necessary. This ongoing care is vital for the long-term success of the procedure. Hospitals offer both inpatient and outpatient services, accommodating a wide range of patient needs. Some patients may require an overnight stay for surgery and recovery, while others can receive outpatient care. This flexibility makes hospitals accessible to a broad spectrum of patients, regardless of the severity of their condition. These factors collectively contribute to the growth of this segment.
Country Insights
The United States has emerged as the dominant country in the North America Male Artificial Urinary Sphincter (AUS) market in 2023, commanding the largest market share in terms of value. This leadership position is underpinned by several factors that collectively contribute to the country's prominence in this specialized healthcare sector. The United States grapples with a high prevalence of urinary incontinence in men, a condition that significantly impacts quality of life and necessitates effective treatment options such as the AUS. This widespread prevalence drives demand for AUS devices and procedures, positioning the United States as a key market for this medical intervention. The high disposable income of patients in the United States plays a pivotal role in driving market dominance. With a culture of prioritizing health and wellness, American patients are more willing and able to invest in advanced medical technologies and procedures to address urinary incontinence issues. This financial capacity enhances accessibility to AUS devices and procedures, further solidifying the United States' position as a dominant market player.
The ready availability of AUS devices and procedures in the United States contributes to its market dominance. AUS devices are typically covered by insurance, making them accessible to a broad spectrum of patients. While patients may be responsible for some out-of-pocket costs, the widespread availability of insurance coverage mitigates financial barriers to access. The United States boasts a large pool of urologists with expertise in AUS implantation procedures, ensuring patients have access to skilled healthcare professionals for diagnosis, treatment, and follow-up care. AUS devices are readily found at at most hospitals and surgery centers across the country, further facilitating patient access and enhancing market penetration.
Recent Developments
- According to an article published in September 2023, the study focused on the initial implantation of the new artificial urinary sphincter, UroActive (UroMems), in the first patient, with a follow-up at 3 months post-activation. It's a prospective, open-label, non-randomized, multi-center, single-arm study where subjects serve as their own control. The aim is to assess the therapy's feasibility. Primary outcomes include the rate of explants and revisions six months after device activation, along with the rate of successful device activations. The main secondary outcome measure is the percentage of subjects experiencing a 50% or greater reduction in 24-hour pad weight at 90, 185, and 365 days post-activation. The study plans to include six patients in total.
- In December 2023, UroMems has hit a significant milestone in advancing the first automated artificial urinary sphincter towards market release, following the successful achievement of both primary and secondary endpoints in its clinical feasibility study. The study (NCT05547672) involved six male patients with stress urinary incontinence who had not benefited from other treatments. According to UroMems, the group treated with its UroActive device achieved the six-month primary endpoints, which included metrics on explant and revision rates, as well as device activation success. The outcomes from this prospective, multicenter study will inform the design and planning of an upcoming pivotal trial in Europe and the US.
Key Market Players
- BostonScientific Corporation
- Rigicon, Inc.
- TeleflexIncorporated
- GE HealthCareTechnologies, Inc.
- Health, Inc.
- MedlineIndustries, LP
- Henry Schein,Inc.
- Becton,Dickinson and Company
- Owens &Minor, Inc.
- Illumina, Inc.
| By Type | By End User | By Country |
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy